AP
IMGO

AlpInvest Partners’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

AlpInvest Partners’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,156
Closed -$404K – 33
2022
Q2 		$404K Sell
30,156
-60,313
-67% -$957K 0.14% 21
2022
Q1 		$1.74M Buy
+90,469
New +$1.88M 0.56% 14

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

AlpInvest Partners's IMGO Position: Q3 2022 in Review

AlpInvest Partners sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q3 2022, closing a stake of 30,156 shares — an estimated $404K sold.

AlpInvest Partners first reported a position in IMGO in Q1 2022 and held it in 2 quarters. The position peaked at $1.74M in Q1 2022. 65 funds tracked by Wall St. Rank hold IMGO as of Q3 2022.

  • AlpInvest Partners reported no remaining Imago BioSciences, Inc. Common stock position as of Q3 2022 after selling out during the quarter.
  • AlpInvest Partners sold 30,156 Imago BioSciences, Inc. Common stock shares in Q3 2022, an estimated $404K.
  • AlpInvest Partners first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 2 quarters.
  • AlpInvest Partners's Imago BioSciences, Inc. Common stock position peaked at $1.74M in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q3 2022.

Based on AlpInvest Partners's 13F filing for Q3 2022, filed 10 Nov 2022.